| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Inmed Pharmaceuticals Inc.'s insiders have accumulated 155,580 shares worth roughly $204K on balance. In the past 30 days, 1 insider bought and 0 sold. Purchases have clustered in the most recent filings.
Leading the buying is ADAR1 Capital Management, LLC (10% Owner), now holding an estimated $1.3M in INM.
INM sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 956.6K | $1.26M | +64.5K | |
| 10% | 743.1K | $1.15M | - | |
| CEO | 49.0K | - | - | |
| COO | 25.4K | - | - | |
| CFO | 24.3K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 28, 2021 | Adams Eric A | President &CEO | Buy | 11,400 | $1.75 | $19,984.20 | +70.9% | -22.5% | -87.2% | |
| Sep 28, 2021 | Colwill Bruce | CFO | Buy | 5,000 | $1.77 | $8,840.00 | +330.0% | -22.5% | -87.2% |